Related Experiment Video
Updated: May 29, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Management of HIV and hepatitis C virus infections in resource-limited settings
Ponsiano Ocama1, Emmanuel Seremba
1Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. ponsianoocama@yahoo.com
Insights
HIV and hepatitis C virus (HCV) are prevalent in resource-limited settings (RLSs), with regional differences in transmission. Prevention through blood screening and sterile equipment is crucial for curbing spread.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- HIV and Hepatitis C Virus (HCV) pose significant global health challenges.
- Resource-limited settings (RLSs) bear a disproportionate burden of these infections.
Purpose of the Study:
- To present an updated review on the epidemiology of HIV and HCV in RLSs.
- To discuss current management strategies for HIV and HCV in RLSs.
Main Methods:
- Review of epidemiological data on HIV and HCV prevalence.
- Analysis of transmission routes in various RLSs.
- Assessment of management and prevention challenges.
Main Results:
- Global HIV prevalence is 33.3 million, with 22.5 million in sub-Saharan Africa.
- Hepatitis C affects 170 million globally, predominantly in RLSs.
- Transmission modes vary, including injection drug use, medical procedures, and blood transfusions, with rising injection drug use in RLSs.
Conclusions:
- HIV and HCV are highly prevalent in RLSs, exhibiting regional transmission variations.
- Effective management is challenged by resource limitations.
- Prevention strategies, including donor blood screening and sterile instrument use, are vital for controlling transmission.
Purpose Of Review:
To provide an update on the epidemiology and management of HIV and hepatitis C virus (HCV) in resource-limited settings (RLSs).
Recent Findings:
The global prevalence of HIV is 33.3 million people of whom 22.5 million live in sub-Saharan Africa. Hepatitis C affects 170 million people globally with majority of the infected persons living in sub-Saharan Africa and other RLSs. Transmission of these viruses varies greatly even within the RLSs. In the RLSs in Europe, Asia and Central/South America, most transmissions occur through injection drug use, whereas in Africa use of needles for medical treatment and blood transfusion may be the main modes of transmission. However, generally there is a rise in injection drug use even in RLSs.
Summary:
Hepatitis C and HIV are common infections and are more prevalent in RLSs, but there are regional differences in transmission even in RLSs. Treatment is difficult in some of the RLSs and prevention by screening donor blood as well and use of sterile instruments in treatment of patients will be important in curbing transmission in some of these settings.
Related Concept Videos
Hepatitis
Retrovirus Life Cycles
Sexually Transmitted Infections
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Cryptococcal Meningitis

